Author: Kevin L. Zacharoff
Naloxone received FDA approval for the treatment of opioid overdose in 1971. Only recently has its use at the community level become more commonplace. Dr. Zacharoff looks at naloxone's role in improving the safety and efficacy of opioid analgesics, and in arresting the surge in unintended opioid related fatalities.
Posted on February 13, 2018